FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
Report: Polypharmacy climbed among older adults from 1999 to 2020
By
Kristen Fischer
Jul 02, 2024
The number of older Americans over the age of 65 not living in healthcare facilities who used prescription medications rose from 1999 through the mid-2000s and hasn’t changed much since. The percentage...
Amazon expands mail-order subscriptions to Prime members on Medicare
By
Kristen Fischer
Jun 19, 2024
Amazon.com is letting Prime members on Medicare join its RxPass mail-order prescription service for just $5 a month. The move could save older adults more money on out-of-pocket costs for generic prescription...